Compound Information | SONAR Target prediction | Name: | 2-(4,4-dimethylcyclohexyl)propan-2-ol | Unique Identifier: | NRB 02318 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C11H22O | Molecular Weight: | 148.117 g/mol | X log p: | -0.528 (online calculus) | Lipinksi Failures | 0 | TPSA | 0 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 1 | Rotatable Bond Count: | 1 | Canonical Smiles: | CC(C)(O)C1CCC(C)(C)CC1 | Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Drug_type: | Experimental | Drugbank_id: | EXPT00530 | Logp: | 3.73 | Drug_category: | Sex Hormone-Binding Globulin inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
SWE1 |
Replicates: |
2 |
Raw OD Value: r im |
0.6354±0.00643467 |
Normalized OD Score: sc h |
0.8382±0.0241815 |
Z-Score: |
-9.8086±1.09272 |
p-Value: |
8.13258e-20 |
Z-Factor: |
0.230419 |
Fitness Defect: |
43.9558 |
Bioactivity Statement: |
Active |
Experimental Conditions | | Library: | Maybridge1000 | Plate Number and Position: | 8|A8 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 21.40 Celcius | Date: | 2007-08-22 YYYY-MM-DD | Plate CH Control (+): | 0.03955±0.00272 | Plate DMSO Control (-): | 0.74005±0.01428 | Plate Z-Factor: | 0.9201 |
| png ps pdf |
4901 |
17-(1-hydroxyethyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phen anthren-3-ol |
6548 |
3,7-dimethyloctan-3-ol |
6665 |
(3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,1 6,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
6743 |
17-(5-ethyl-6-methyl-heptan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyc lopenta[a]phenanthren-3-ol |
7391 |
4-tert-butylcyclohexan-1-ol |
7507 |
cyclohexylmethanol |
internal high similarity DBLink | Rows returned: 38 | 1 2 3 4 5 6 7 Next >> |
active | Cluster 1300 | Additional Members: 1 | Rows returned: 0 | |
|